DrugDashboards

Rocuronium

Rocuronium · ROCURONIUM BROMIDE 100 mg/10mL · Injection, Solution · Intravenous · Piramal Critical Care Inc

NDC 66794-0229-41 · 10 VIAL in 1 CARTON / 10 mL in 1 VIAL · ANDA · View full market →

The short version

Just 3 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now — FDA lists the reason as “demand increase for the drug.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$74.00
Reported to Texas DSHS · 2026 annual filing · Piramal Critical Care

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2024)

$587
277 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.4%chance of a new FDA shortage posting for rocuronium (injectable) in the next 90 days

sterile injectable · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA210437
TE code
AP
Approval date
Aug 13, 2019
Patents / exclusivity
None on file

Shortage history

  • In shortage now Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)Feb 15, 2023
    Demand increase for the drug
    month 43 — 2× the typical 20-month injectable shortage
  • In shortage now Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)Feb 15, 2023
    Demand increase for the drug
    month 43 — 2× the typical 20-month injectable shortage

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Rocuronium (Injection, Solution)

LabelerStrengthFirst seenLast seen
Bryant Ranch PrepackROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.ROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Piramal Critical Care IncROCURONIUM BROMIDE 100 mg/10mLJul 15, 2026Sep 2, 2026
Piramal Critical Care IncROCURONIUM BROMIDE 50 mg/5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Rocuronium — NDC 66794-0229-41," retrieved September 3, 2026, https://drugdashboards.com/drug/66794022941.

Free to cite with attribution — see how the data is put together.